- Papers in database
- 2
- Primary author
- 1 paper
- Years active
- 2019 – 2022
- Health outcomes studied
- 1
Health Outcomes Studied
Papers (2)
- 2022Randomized control trial on the efficacy of Limosilactobacillus reuteri ATCC PTA 4659 in reducing inflammatory markers in acute uncomplicated diverticulitis10.1097/MEG.0000000000002342
- 2019Primary authorSupplementation with Lactobacillus reuteri ATCC PTA 4659 in patients affected by acute uncomplicated diverticulitis: a randomized double-blind placebo controlled trial10.1007/s00384-019-03295-1